(Q39553054)

13 September 2017

title

Methylseleninic acid inhibits HDAC activity in diffuse large B-cell lymphoma cell lines (English)

1 reference

diffuse large B-cell lymphoma

13 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

1 reference

based on heuristic

inferred from title

author

Heidi Goenaga-Infante

2

object named as

Heidi Goenaga-Infante

1 reference

13 September 2017

Shireen Kassam

1

1 reference

13 September 2017

Lenushka Maharaj

3

1 reference

13 September 2017

Crispin T Hiley

4

1 reference

13 September 2017

Simone Juliger

5

1 reference

13 September 2017

Simon P Joel

6

1 reference

13 September 2017

publication date

26 April 2011

1 reference

Cancer Chemotherapy and Pharmacology

13 September 2017

published in

1 reference

13 September 2017

volume

68

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

815-821

1 reference

Selenium speciation analysis using inductively coupled plasma-mass spectrometry

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

NF-kappaB activation, dependent on acetylation/deacetylation, contributes to HIF-1 activity and migration of bone metastatic breast carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Tumor vascular maturation and improved drug delivery induced by methylselenocysteine leads to therapeutic synergy with anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Selective modulation of the therapeutic efficacy of anticancer drugs by selenium containing compounds against human tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Targeting tumor angiogenesis with histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

A Phase I and pharmacokinetic study of selenomethionine in combination with a fixed dose of irinotecan in solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Capabilities of HPLC with APEX-Q nebulisation ICP-MS and ESI MS/MS to compare selenium uptake and speciation of non-malignant with different B cell lymphoma lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Locally generated methylseleninic acid induces specific inactivation of protein kinase C isoenzymes: relevance to selenium-induced apoptosis in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-kappaB inhibition and the rapid generation of other selenium species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

The activity of methylated and non-methylated selenium species in lymphoma cell lines and primary tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Presentation serum selenium predicts for overall survival, dose delivery, and first treatment response in aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Alpha-keto acid metabolites of naturally occurring organoselenium compounds as inhibitors of histone deacetylase in human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Alpha-keto acid metabolites of organoselenium compounds inhibit histone deacetylase activity in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Cystathionine gamma-lyase contributes to selenomethionine detoxification and cytosolic glutathione peroxidase biosynthesis in mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

Selenium in cancer prevention: a review of the evidence and mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00280-011-1649-1

10.1007/S00280-011-1649-1

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference